A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Apr; 125(1):54-8.
-
Adult
-
Adult
-
Aged
-
Aged
-
Aged, 80 and over
-
Aged, 80 and over
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Combined Chemotherapy Protocols
-
Antineoplastic Combined Chemotherapy Protocols
-
Bevacizumab
-
Bevacizumab
-
Carboplatin
-
Carboplatin
-
Dose-Response Relationship, Drug
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Drug Administration Schedule
-
Fallopian Tube Neoplasms
-
Fallopian Tube Neoplasms
-
Feasibility Studies
-
Feasibility Studies
-
Female
-
Female
-
Humans
-
Humans
-
Infusions, Intravenous
-
Infusions, Intravenous
-
Infusions, Parenteral
-
Infusions, Parenteral
-
Maximum Tolerated Dose
-
Maximum Tolerated Dose
-
Middle Aged
-
Middle Aged
-
Neoplasm Staging
-
Neoplasm Staging
-
Ovarian Neoplasms
-
Ovarian Neoplasms
-
Paclitaxel
-
Paclitaxel
-
Peritoneal Neoplasms
-
Peritoneal Neoplasms